Stay updated on Pembrolizumab in Glioblastoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Glioblastoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Glioblastoma Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    The record describes a completed randomized Phase I/II trial of IMA950/Poly-ICLC, with or without pembrolizumab, for relapsing glioblastoma. It also provides participant eligibility, study measures, and the trial’s location and dates.
    Difference
    52%
    Check dated 2026-11-08T00:59:40.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.2 to v3.8.0, while the study record remains unavailable behind a 403 error.
    Difference
    0.2%
    Check dated 2026-10-31T19:26:25.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    A notice was added announcing NIH website updates and a transition from the term “Artificial Intelligence” to “Super Intelligence.”
    Difference
    1%
    Check dated 2026-10-24T20:26:31.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The footer revision identifier was updated from v3.7.1 to v3.7.2 on the page displaying a 403 error.
    Difference
    0.2%
    Check dated 2026-10-17T22:01:23.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The footer revision identifier changes from v3.7.0 to v3.7.1 on the ClinicalTrials.gov error page; the study record remains inaccessible.
    Difference
    0.2%
    Check dated 2026-10-10T22:04:36.000Z thumbnail image
  7. Check
    44 days ago
    Change Detected
    Summary
    The page continues to show a 403 Forbidden error instead of the clinical-trial study record, with no visible content or layout changes.
    Difference
    0.2%
    Check dated 2026-10-03T21:41:22.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Glioblastoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Glioblastoma Clinical Trial page.